Endocyte's IPO

Endocyte raised a round of funding on February 04, 2011. Investors include Public.

Endocyte is a biotechnology company developing receptor-targeted therapeutics or "smart drugs" for the treatment of cancer and autoimmune diseases. The Company focuses on certain types of cancer cells…

Articles about Endocyte's IPO: